Tizanidine Tablet
Product Images NDC 50090-7889

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-7889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

Chemical structure of Tizanidine hydrochloride, showing the arrangement of atoms including chlorine, nitrogen, sulfur, and hydrogen in the compound.*

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

A line graph showing plasma concentration of Tizanidine (ng/mL) on the y-axis versus hours from dosing on the x-axis, up to 26 hours. It compares four curves representing 4 mg Tizanidine tablets and capsules taken with and without food, depicting absorption and elimination profiles over time.*

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

A line graph showing improvement in Ashworth Score over time (0 to 6 hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo groups. The graph includes error bars indicating variability at each time point for the three groups.*

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

A line chart showing improvement in Ashworth Score with tizanidine (mean dose 28.8 mg) compared to placebo over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine shows greater improvement indicated by lower scores, with error bars displayed for each data point.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Label Image (Lbl500907889)

Tizanidine USP 4 mg oral tablets packaging label showing lot number S5500-0, NDC 50090-7889-0. Label indicates each tablet contains 4.375 mg tizanidine hydrochloride, equivalent to 4 mg tizanidine base. The bottle contains 90 tablets and is labeled by A-S Medication Solutions, Libertyville, Illinois. Storage instructions specify 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.